(Q37815474)

23 August 2017

1 reference

title

Achieving remission as a routine goal of pharmacotherapy in attention-deficit hyperactivity disorder (English)

1 reference

attention deficit hyperactivity disorder

23 August 2017

main subject

0 references

0 references

1 reference

Josep Antoni Ramos-Quiroga

series ordinal

1

1 reference

23 August 2017

Miguel Casas

2

1 reference

23 August 2017

publication date

1 January 2011

1 reference

23 August 2017

1 reference

23 August 2017

volume

25

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

17-36

1 reference

Hyperactive boys almost grown up. I. Psychiatric status

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11538450-000000000-00000

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11538450-000000000-00000

Assessment of social adjustment by patient self-report

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11538450-000000000-00000

DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11538450-000000000-00000

Estimates of the prevalence of childhood maladjustment in a community survey in Puerto Rico. The use of combined measures

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11538450-000000000-00000

A children's global assessment scale (CGAS)

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11538450-000000000-00000

Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11538450-000000000-00000

Attention deficit/hyperactivity disorder and methylphenidate. A review of height/weight, cardiovascular, and somatic complaint side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11538450-000000000-00000

Attention-deficit/hyperactivity disorder in a population isolate: linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11.

21 January 2018

1 reference

12 December 2020

Age-dependent expression of attention-deficit/hyperactivity disorder symptoms

1 reference

12 December 2020

Persistence of hyperactivity symptoms from childhood to adolescence and associated outcomes

1 reference

12 December 2020

The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder

1 reference

12 December 2020

Remission versus response as the goal of therapy in ADHD: a new standard for the field?

1 reference

12 December 2020

Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment

1 reference

12 December 2020

A genomewide scan for loci involved in attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study

1 reference

12 December 2020

Efficacy and safety of Ritalin LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorder

1 reference

12 December 2020

Effect of switching drug formulations from immediate-release to extended-release OROS methylphenidate : a chart review of Spanish adults with attention-deficit hyperactivity disorder

1 reference

12 December 2020

Establishment of remission criteria for anxiety disorders.

1 reference

12 December 2020

Genome-wide linkage analysis of ADHD using high-density SNP arrays: novel loci at 5q13.1 and 14q12.

1 reference

12 December 2020

Brain activation gradients in ventrolateral prefrontal cortex related to persistence of ADHD in adolescent boys

1 reference

12 December 2020

1 reference

12 December 2020

Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder

1 reference

12 December 2020

Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder

1 reference

12 December 2020

Molecular genetics of attention-deficit/hyperactivity disorder

1 reference

12 December 2020

12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode

1 reference

12 December 2020

A post hoc analysis of d-threo-methylphenidate hydrochloride (focalin) versus d,l-threo-methylphenidate hydrochloride (ritalin).

1 reference

12 December 2020

Switching from neurostimulant therapy to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder : clinical approaches and review of current available evidence

1 reference

12 December 2020

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

1 reference

12 December 2020

Meta-analysis of suicide-related behavior events in patients treated with atomoxetine

1 reference

12 December 2020

Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults

1 reference

12 December 2020

The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies

1 reference

12 December 2020

Association study of 10 genes encoding neurotrophic factors and their receptors in adult and child attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Remission in schizophrenia: proposed criteria and rationale for consensus

1 reference

12 December 2020

The adolescent outcome of hyperactive children diagnosed by research criteria--III. Mother-child interactions, family conflicts and maternal psychopathology

1 reference

12 December 2020

Psychiatric comorbidity associated with DSM-IV ADHD in a nonreferred sample of twins

1 reference

12 December 2020

Patterns of diagnostic comorbidity in a community sample of children aged 9 through 16 years.

1 reference

12 December 2020

Contribution of 5-HT2A receptor gene -1438A>G polymorphism to outcome of attention-deficit/hyperactivity disorder in adolescents.

1 reference

12 December 2020

A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Cardiovascular effects of atomoxetine in children, adolescents, and adults

1 reference

12 December 2020

Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies

1 reference

12 December 2020

Monoamine oxidase A gene polymorphism predicts adolescent outcome of attention-deficit/hyperactivity disorder.

1 reference

12 December 2020

Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder

1 reference

12 December 2020

Attention deficit hyperactivity disorder: advances in cognitive, neurobiological, and genetic research

1 reference

12 December 2020

Stability of executive function deficits into young adult years: a prospective longitudinal follow-up study of grown up males with ADHD.

1 reference

12 December 2020

Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication

1 reference

12 December 2020

Effect of candidate gene polymorphisms on the course of attention deficit hyperactivity disorder

1 reference

12 December 2020

Linkage analysis of attention deficit hyperactivity disorder

1 reference

12 December 2020

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

1 reference

12 December 2020

The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study

1 reference

12 December 2020

Effects of atomoxetine on attention-deficit/hyperactivity disorder in clinical pediatric treatment settings: a naturalistic study

1 reference

12 December 2020

Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

1 reference

12 December 2020

Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study

1 reference

12 December 2020

Longitudinal mapping of cortical thickness and clinical outcome in children and adolescents with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder

1 reference

12 December 2020

Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community

1 reference

12 December 2020

Attention-deficit hyperactivity disorder: magnetic resonance imaging morphometric analysis of the corpus callosum

1 reference

12 December 2020

Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD

1 reference

12 December 2020

Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention deficit hyperactivity disorder: a pharmacogenetic study.

1 reference

12 December 2020

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings

1 reference

12 December 2020

Normalized functioning in youths with persistent attention-deficit/hyperactivity disorder.

1 reference

12 December 2020

Attention deficit hyperactivity disorder in adults

1 reference

12 December 2020

A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q.

1 reference

12 December 2020

Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB.

1 reference

12 December 2020

Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis

1 reference

12 December 2020

Clinical significance: A statistical approach to defining meaningful change in psychotherapy research

1 reference

12 December 2020

Assessing attention-deficit/hyperactivity disorder in adults: focus on rating scales.

1 reference

12 December 2020

Pooled genome-wide linkage data on 424 ADHD ASPs suggests genetic heterogeneity and a common risk locus at 5p13

1 reference

12 December 2020

A genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs

1 reference

12 December 2020

Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder

1 reference

12 December 2020

European clinical guidelines for hyperkinetic disorder -- first upgrade

1 reference

12 December 2020

Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type.

1 reference

12 December 2020

Sex differences in dopamine receptors and their relevance to ADHD.

1 reference

12 December 2020

Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.

1 reference

12 December 2020

The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis

1 reference

12 December 2020

Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder.

1 reference

12 December 2020

Hepatic events associated with atomoxetine treatment for attention-deficit hyperactivity disorder

1 reference

12 December 2020

Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers

1 reference

12 December 2020

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Slowing of growth in height and weight on stimulants: a characteristic pattern

1 reference

12 December 2020

Predictive factors for persistent use and compliance of immediate-release methylphenidate: a 36-month naturalistic study

1 reference

12 December 2020

Depression in attention deficit hyperactivity disorder (ADHD) children: "true" depression or demoralization?

1 reference

12 December 2020

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

1 reference

12 December 2020

The effects of attention-deficit/hyperactivity disorder on employment and household income.

1 reference

12 December 2020

Injuries to children with attention deficit hyperactivity disorder

1 reference

12 December 2020

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial

1 reference

12 December 2020

A high-density SNP linkage scan with 142 combined subtype ADHD sib pairs identifies linkage regions on chromosomes 9 and 16.

1 reference

12 December 2020

The worldwide prevalence of ADHD: a systematic review and metaregression analysis

1 reference

12 December 2020

10.2165/11538450-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

23 August 2017

1021917176

0 references

1 reference